| Literature DB >> 28694848 |
Yingxia Sun1, Junliang Shang1,2, Jin-Xing Liu1, Shengjun Li1, Chun-Hou Zheng1,3.
Abstract
BACKGROUND: Identifying epistasis or epistatic interactions, which refer to nonlinear interaction effects of single nucleotide polymorphisms (SNPs), is essential to understand disease susceptibility and to detect genetic architectures underlying complex diseases. Though many works have been done for identifying epistatic interactions, due to their methodological and computational challenges, the algorithmic development is still ongoing.Entities:
Keywords: Ant colony optimization; Bayesian network; Epistatic interactions; Mutual information
Year: 2017 PMID: 28694848 PMCID: PMC5500974 DOI: 10.1186/s13040-017-0143-7
Source DB: PubMed Journal: BioData Min ISSN: 1756-0381 Impact factor: 2.522
Fig. 1The pseudo code of epiACO
Details of 5 commonly used benchmark models of 2-SNP epistatic interactions
| Models | MAF( | MAF( | Prevalence | Penetrance function | ||||
|---|---|---|---|---|---|---|---|---|
| Genotypes (SNP | Genotypes (SNP | |||||||
|
|
|
| ||||||
| ME Models | Model 1 | 0.300 | 0.200 | 0.100 |
| 0.087 | 0.087 | 0.087 |
|
| 0.087 | 0.146 | 0.190 | |||||
|
| 0.087 | 0.190 | 0.247 | |||||
| Model 2 | 0.400 | 0.400 | 0.050 |
| 0.042 | 0.042 | 0.042 | |
|
| 0.240 | 0.270 | 0.420 | |||||
|
| 0.240 | 0.440 | 0.090 | |||||
| NME Models | Model 3 | 0.500 | 0.500 | 0.300 |
| 0.470 | 0.230 | 0.270 |
|
| 0.240 | 0.270 | 0.420 | |||||
|
| 0.240 | 0.440 | 0.090 | |||||
| Model 4 | 0.400 | 0.400 | 0.171 |
| 0.068 | 0.299 | 0.017 | |
|
| 0.289 | 0.044 | 0.285 | |||||
|
| 0.048 | 0.262 | 0.174 | |||||
| Model 5 | 0.500 | 0.500 | 0.010 |
| 0.000 | 0.000 | 0.100 | |
|
| 0.000 | 0.050 | 0.000 | |||||
|
| 0.100 | 0.000 | 0.000 | |||||
Prevalence is the proportion of samples that occur a disease. Penetrance is the probability of the occurrence of a disease given a particular genotype.MAF(a) is the minor allele frequency of a. AA, Aa, and aa are homozygous common genotype, heterozygous genotype, and homozygous minor genotype
The average detection power and the average running time with their respective standard deviations of compared methods on 100-SNP data sets
| Evaluation measures | Models | epiMODE | TEAM | BOOST | SNPRuler | AntEpiSeeker | AntMiner | MACOED | IACO | epiACO | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Detection power (%) | ME Models | Model 1 | 45.42 ± 3.58 | 89.75 ± 1.22 | 0.00 ± 0.00 | 0.00 ± 0.00 | 81.95 ± 2.57 | 89.51 ± 1.67 | 76.45 ± 5.10 | 100.00 ± 0.0 | 100.00 ± 0.0 |
| Model 2 | 0.00 ± 0.00 | 14.03 ± 0.15 | 0.00 ± 0.00 | 0.00 ± 0.00 | 33.57 ± 7.28 | 86.75 ± 4.36 | 84.52 ± 4.90 | 94.37 ± 1.84 | 97.85 ± 1.34 | ||
| NME Modes | Model 3 | 0.00 ± 0.00 | 100.00 ± 0.0 | 100.00 ± 0 | 100.00 ± 0.0 | 26.83 ± 6.25 | 85.47 ± 5.00 | 74.67 ± 4.90 | 26.83 ± 6.08 | 75.25 ± 5.83 | |
| Model 4 | 0.00 ± .000 | 79.77 ± 1.76 | 100.00 ± 0 | 100.00 ± 0.0 | 42.33 ± 7.87 | 100.00 ± 0.0 | 82.13 ± 3.74 | 30.14 ± 7.21 | 81.87 ± 6.33 | ||
| Model 5 | 0.00 ± .000 | 0.00 ± 0.00 | 100.00 ± 0 | 98.52 ± 1.48 | 76.45 ± 4.12 | 100.00 ± 0.0 | 76.33 ± 3.46 | 44.67 ± 11.4 | 75.62 ± 7.75 | ||
| Running time (second) | ME Models | Model 1 | 98.22 ± 0.81 | 35.13 ± 0.26 | 0.33 ± 0.06 | 0.93 ± 0.02 | 28.73 ± 0.50 | 1100.50 ± 26.08 | 52.56 ± 0.57 | 25.03 ± 0.45 | 23.48 ± 0.44 |
| Model 2 | 95.70 ± 0.75 | 34.78 ± 0.26 | 0.28 ± 0.04 | 0.96 ± 0.03 | 29.08 ± 0.54 | 1101.60 ± 65.09 | 53.64 ± 0.77 | 28.22 ± 0.56 | 25.07 ± 0.49 | ||
| NME Models | Model 3 | 97.36 ± 0.64 | 35.02 ± 0.27 | 0.27 ± 0.03 | 0.97 ± 0.02 | 28.74 ± 0.35 | 1002.90 ± 52.95 | 59.92 ± 0.57 | 26.78 ± 0.77 | 25.77 ± 0.37 | |
| Model 4 | 99.21 ± 0.83 | 34.90 ± 0.26 | 0.29 ± 0.05 | 0.98 ± 0.02 | 28.14 ± 0.40 | 1017.00 ± 36.01 | 59.68 ± 0.70 | 26.21 ± 0.44 | 18.29 ± 0.37 | ||
| Model 5 | 95.89 ± 0.70 | 35.22 ± 0.26 | 0.28 ± 0.04 | 0.97 ± 0.02 | 28.77 ± 0.53 | 1102.30 ± 27.59 | 52.76 ± 0.66 | 26.14 ± 0.37 | 25.19 ± 0.47 | ||
The average detection power and the average running time with their respective standard deviations of compared methods on 1000-SNP data sets
| Evaluation measures | Models | AntEpiSeeker | MACOED | IACO | epiACO | |
|---|---|---|---|---|---|---|
| Detection power (%) | ME Models | Model 1 | 36.10 ± 3.86 | 16.33 ± 5.16 | 100.00 ± 0.00 | 100.00 ± 0.00 |
| Model 2 | 0.00 ± .0.00 | 18.14 ± 4.75 | 17.62 ± 4.67 | 35.33 ± 3.26 | ||
| NME Modes | Model 3 | 0.00 ± .0.00 | 9.80 ± 2.74 | 7.00 ± 2.93 | 10.30 ± 2.69 | |
| Model 4 | 0.00 ± .0.00 | 6.10 ± 2.94 | 4.90 ± 2.19 | 9.90 ± 2.83 | ||
| Model 5 | 0.00 ± .0.00 | 9.60 ± 3.34 | 5.70 ± 2.77 | 11.23 ± 3.57 | ||
| Running time (second) | ME Models | Model 1 | 357.11 ± 13.08 | 323.81 ± 18.47 | 301.27 ± 13.43 | 231.38 ± 12.65 |
| Model 2 | 305.40 ± 16.33 | 334.01 ± 17.74 | 270.31 ± 18.91 | 229.33 ± 15.91 | ||
| NME Models | Model 3 | 281.08 ± 17.23 | 337.49 ± 16.72 | 253.00 ± 18.82 | 253.41 ± 12.57 | |
| Model 4 | 262.75 ± 14.26 | 345.21 ± 19.41 | 277.04 ± 14.37 | 241.41 ± 10.02 | ||
| Model 5 | 305.99 ± 14.88 | 354.87 ± 13.48 | 314.40 ± 12.35 | 267.49 ± 11.63 | ||
Fig. 2The convergence and contribution of epiACO with the parameter settings being the same as those of the first experiment
Top 10 captured epistatic interactions associated with AMD. CFH: complement factor H. N/A: no gene is available. MED27: mediator complex subunit 27. KDM4C: lysine (K)-specific demethylase 4C. NCALD: neurocalcin delta. ISCA1: iron-sulfur cluster assembly 1. NEDD9: neural precursor cell expressed developmentally down-regulated 9
| SNP 1 | SNP 2 |
| ||||
|---|---|---|---|---|---|---|
| Name | Gene | Chromosome | Name | Gene | Chromosome | |
| rs380390 |
| 1 | rs1363688 |
| 5 | 4.5728 e-09 |
| rs380390 |
| 1 | rs2224762 |
| 9 | 3.2929 e-08 |
| rs380390 |
| 1 | rs1374431 |
| 2 | 3.9086 e-08 |
| rs1740752 |
| 10 | rs1368863 |
| 11 | 9.8438 e-08 |
| rs380390 |
| 1 | rs223607 |
| 6 | 1.9797 e-07 |
| rs1329428 |
| 1 | rs9328536 |
| 9 | 2.1498 e-07 |
| rs1740752 |
| 10 | rs943008 |
| 6 | 3.8365 e-07 |
| rs380390 |
| 1 | rs718263 |
| 8 | 5.1901 e-07 |
| rs380390 |
| 1 | rs2402053 |
| 7 | 1.1131 e-05 |
| rs380390 |
| 1 | rs10512174 |
| 9 | 3.9083 e-05 |